INOVIO is focused on developing and commercializing DNA medicines to help protect people from infectious diseases and help treat people with cancer and HPV-associated diseases. In the last several years INOVIO has had its data published in several prominent peer-reviewed medical journals including:
npj Vaccines
October 2021
The Journal of Infectious Diseases
January 2022
Open Forum Infectious Diseases
December 2021
Nature Communications
May 2020
The Lancet Infectious Diseases
July 2019
Title | Disease Target | Product |
---|---|---|
DNA-encoded bispecific T cell engagers and antibodies present long-term antitumor activity JCI Insight — April 2019 |
HER2 |
© Copyright 2023 INOVIO Pharmaceuticals. All rights reserved.